L Helbig1, A Yaromina, S N Sriramareddy, S Böke, L Koi, H D Thames, M Baumann, D Zips. 1. Dept. of Radiation Oncology/ OncoRay National Center for Radiation Research, Medical Faculty and University Hospital Carl Gustav Carus Technische Universität Dresden, Fetscherstr. 74, 01307, Dresden, Germany.
Abstract
BACKGROUND AND PURPOSE: Hypoxia and reoxygenation are important determinants of outcome after radiotherapy. HIF-1α is a key molecule involved in cellular response to hypoxia. HIF-1α expression levels have been shown to change after irradiation. The objective of the present study was to explore the prognostic value of HIF-1α expression during fractionated irradiation. MATERIALS AND METHODS: Six human squamous cell carcinoma models xenografted in nude mice were analysed. Tumours were excised after 3, 5 and 10 fractions. HIF-1α expression was quantified by western blot. For comparative analysis, previously published data on local tumour control data and pimonidazole hypoxic fraction was used. RESULTS: HIF-1α expression in untreated tumours exhibited intertumoural heterogeneity and did not correlate with pimonidazole hypoxic fraction. During fractionated irradiation the majority of tumour models exhibited a decrease in HIF-1α expression, whereas in UT-SCC-5 no change was observed. Neither kinetics nor expression levels during fractionated irradiation correlated with local tumour control. CONCLUSION: Our data do not support the use of HIF-1α determined during treatment as a biomarker to predict outcome after fractionated irradiation.
BACKGROUND AND PURPOSE:Hypoxia and reoxygenation are important determinants of outcome after radiotherapy. HIF-1α is a key molecule involved in cellular response to hypoxia. HIF-1α expression levels have been shown to change after irradiation. The objective of the present study was to explore the prognostic value of HIF-1α expression during fractionated irradiation. MATERIALS AND METHODS: Six humansquamous cell carcinoma models xenografted in nude mice were analysed. Tumours were excised after 3, 5 and 10 fractions. HIF-1α expression was quantified by western blot. For comparative analysis, previously published data on local tumour control data and pimonidazole hypoxic fraction was used. RESULTS: HIF-1α expression in untreated tumours exhibited intertumoural heterogeneity and did not correlate with pimonidazole hypoxic fraction. During fractionated irradiation the majority of tumour models exhibited a decrease in HIF-1α expression, whereas in UT-SCC-5 no change was observed. Neither kinetics nor expression levels during fractionated irradiation correlated with local tumour control. CONCLUSION: Our data do not support the use of HIF-1α determined during treatment as a biomarker to predict outcome after fractionated irradiation.
Authors: David L Schwartz; Garth Powis; Arun Thitai-Kumar; Yi He; James Bankson; Ryan Williams; Robert Lemos; Junghwan Oh; Andrei Volgin; Suren Soghomonyan; Ryuichi Nishii; Mian Alauddin; Uday Mukhopadhay; Zhenghong Peng; William Bornmann; Juri Gelovani Journal: Mol Cancer Ther Date: 2009-04 Impact factor: 6.261
Authors: Ala Yaromina; Theresa Kroeber; Andreas Meinzer; Simon Boeke; Howard Thames; Michael Baumann; Daniel Zips Journal: Int J Radiat Oncol Biol Phys Date: 2011-04-12 Impact factor: 7.038
Authors: Fang Li; Pierre Sonveaux; Zahid N Rabbani; Shanling Liu; Bin Yan; Qian Huang; Zeljko Vujaskovic; Mark W Dewhirst; Chuan-Yuan Li Journal: Mol Cell Date: 2007-04-13 Impact factor: 17.970
Authors: Hilde L K Janssen; Karin M G Haustermans; Debbie Sprong; Gerard Blommestijn; Ingrid Hofland; Frank J Hoebers; Elke Blijweert; James A Raleigh; Gregg L Semenza; Mahesh A Varia; Alfons J Balm; Marie Louise F van Velthuysen; Pierre Delaere; Raf Sciot; Adrian C Begg Journal: Int J Radiat Oncol Biol Phys Date: 2002-12-01 Impact factor: 7.038
Authors: Dirk Vordermark; Astrid Katzer; Kurt Baier; Peter Kraft; Michael Flentje Journal: Int J Radiat Oncol Biol Phys Date: 2004-03-15 Impact factor: 7.038
Authors: Arnulf Mayer; Michael Höckel; Alexander Wree; Cornelia Leo; Lars-Christian Horn; Peter Vaupel Journal: Cancer Res Date: 2008-06-15 Impact factor: 12.701
Authors: Priyamal Silva; Nick J Slevin; Philip Sloan; Helen Valentine; Jo Cresswell; David Ryder; Patricia Price; Jarrod J Homer; Catharine M L West Journal: Int J Radiat Oncol Biol Phys Date: 2008-12-01 Impact factor: 7.038
Authors: Saskia E Rademakers; Jasper Lok; Albert J van der Kogel; Johan Bussink; Johannes H A M Kaanders Journal: BMC Cancer Date: 2011-05-12 Impact factor: 4.430